Cyclopharm raises $20 million, seeks another $2 million Radiopharmaceutical imaging company Cyclopharm has successfully completed its institutional placement, raising $20 million before costs. The Placement attracted strong demand from both existing shareholders and from new institutional and sophisticated investors in Australia, Hong Kong, and the UK. A share purchase plan to raise up to $2.0…
Orica announces executive appointments including new CFO Explosives technology group Orica has announced changes to its executive committee. Chief Financial Officer, Kim Kerr has decided to leave Orica and James Crough has been appointed as CFO. James joined Orica in May 2019 as Vice President of Finance, Australia Pacific and Asia. Subsequently, he was Interim…
Cyclopharm’s Technegas radiopharmaceutical imaging system has achieved a streamlined reimbursement approval process in the United States, boosting its prospects in what is the world’s largest market. The Sydney company has received a Coding Determination for Technegas from the Center for Medicare Medicaid Services (CMS), which means users will have a unique identifier which streamlines their…
DroneShield moves to profit on increasing global tensions Drone countermeasure company DroneShield has confirmed it moved to profit in FY23 on the back of rising global tensions and Russia’s invasion of Ukraine. The company reported record contracts and growing cash receipts which reached $73.5 million in FY23, five times the previous year. More than 68…
Radiopharmaceutical systems manufacturer Cyclopharm is expanding its manufacturing and storage capacity at Kingsgrove in Sydney to meet US demand, following approval by the USFDA for sale of the system in the big Uited States market. The Sydney company told investors it was preparing to air freight the first 20 Technegas systems to the USA, with…
Radiopharmaceutical producer Cyclopharm has announced record sales revenue for 1H FY23 of $15.3 million, up 39 percent on the previous corresponding period. Sales of its Technegas product were steady on the previous corresponding period, with third party distribution sales up 116 percent on the PCP to $7.7 million. For the first time third party sales…
